8. Huntington disease Clinical trials / Disease details
Clinical trials : 229 / Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00368849 (ClinicalTrials.gov) | November 2005 | 24/8/2006 | Atomoxetine and Huntington's Disease | Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study | Huntington Disease;Chorea | Drug: atomoxetine;Drug: Matching Placebo | University of Iowa | Eli Lilly and Company | Completed | 18 Years | 65 Years | All | 20 | Phase 2 | United States |